Age: 65.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Alanine aminotransferase, Alanine aminotransferase increased, Blood test, Breast discomfort, Hepatomegaly
Clinical narrative: Liver was swollen, made ALT rise; Liver was swollen, made ALT rise; Felt a heaviness under right breast on the intercostal muscle; intercostal muscle hurts; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  A 65-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Nov2022 at 13:45 as dose 4 (booster), 0.3 ml single (Lot number: GJ3277, Expiration Date: 31Aug2023) at the age of 65 years for covid-19 immunisation. The patient's relevant medical history included: "COVID", start date: Mar2022 (unspecified if ongoing); "COVID", start date: 25Jun2022 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: johnson and johnson coviD-19 vaccine (Dose 1), administration date: 18Feb2021, when the patient was 64-year-old, for COVID-19 immunization; BNT162b2 (Dose 3, lot number: FP7135.), administration date: 03Aug2022, when the patient was 65-year-old, for COVID-19 immunization; johnson and johnson coviD-19 vaccine (Dose 2), administration date: 06Dec2021, when the patient was 64-year-old, for COVID-19 immunization; fluad quad (generic name Flu Vacc, 60mcg (15mcg/4 0.5ml), Manufacturer: Seqirus Inc), administration date: 11Oct2022, when the patient was 65-year-old. The following information was reported: BREAST DISCOMFORT (non-serious) with onset Nov2022, outcome "unknown", described as "Felt a heaviness under right breast on the intercostal muscle"; HEPATOMEGALY (non-serious), ALANINE AMINOTRANSFERASE INCREASED (non-serious) all with onset Nov2022, outcome "unknown" and all described as "Liver was swollen, made ALT rise"; MYALGIA (non-serious) with onset Nov2022, outcome "unknown", described as "intercostal muscle hurts". The events "liver was swollen, made alt rise", "intercostal muscle hurts" and "felt a heaviness under right breast on the intercostal muscle" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient had an adverse reaction which was that caller's liver was swollen and made caller's ALT rise. Going back to gastroenterologist and hepatologist.  This dose would be the 2nd booster of the Pfizer for caller. Started off with Johnson and Johnson COVID-19 vaccine on 18Feb2021, and then another dose of Johnson and Johnson COVID-19 vaccine on 06Dec2021 then on 03Aug2022 had the 1st Pfizer COVID-19 vaccine, had no issues, no problems. Saying this most recent dose was filled on 01Nov2022. Within in 4 days liver was swollen and blew up, feels like gallbladder. Realized after had the vaccine a few days later, a good 3 days later, felt a heaviness under right breast on the intercostal muscle and looked in mirror, realized that liver was swollen that's why intercostal muscle hurts and was pressing into lung. Then had the blood work done on 07Nov2022, because heaviness, did not feel right to touch, something was not right. Was taking showers to calm down, laying down is uncomfortable. Now found that the ALT number had come down to 22. When swollen the most didn't have the bloodwork done but knew more substantially 3 days after up to the time the blood work was done. This week saw doctor on Tuesday, doctor is sending caller for more tests and back for another ultrasound. Had nothing after the dose caller received in Aug, had bloodwork, numbers were the same, checked ALT in Sep and was still 21, Oct was still 21, now ALT is 22. Didn't have the blood work immediately after when liver was swollen the most because caller was waiting for doctor.